nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—MAST1—brain—conduct disorder	0.00909	0.019	CbGeAlD
Bosutinib—TLK1—brain—conduct disorder	0.0081	0.0169	CbGeAlD
Bosutinib—PRKCQ—brain—conduct disorder	0.00798	0.0167	CbGeAlD
Bosutinib—SIK2—brain—conduct disorder	0.00788	0.0165	CbGeAlD
Bosutinib—STK33—brain—conduct disorder	0.00788	0.0165	CbGeAlD
Bosutinib—PKMYT1—brain—conduct disorder	0.00768	0.016	CbGeAlD
Bosutinib—DSTYK—brain—conduct disorder	0.00749	0.0157	CbGeAlD
Bosutinib—CLK3—brain—conduct disorder	0.00749	0.0157	CbGeAlD
Bosutinib—HIPK4—brain—conduct disorder	0.00741	0.0155	CbGeAlD
Bosutinib—EPHB2—brain—conduct disorder	0.00732	0.0153	CbGeAlD
Bosutinib—CASK—brain—conduct disorder	0.00732	0.0153	CbGeAlD
Bosutinib—PHKG1—brain—conduct disorder	0.00732	0.0153	CbGeAlD
Bosutinib—EIF2AK1—brain—conduct disorder	0.00724	0.0151	CbGeAlD
Bosutinib—SRMS—brain—conduct disorder	0.00717	0.015	CbGeAlD
Bosutinib—VRK2—brain—conduct disorder	0.00702	0.0147	CbGeAlD
Bosutinib—EPHA8—brain—conduct disorder	0.00702	0.0147	CbGeAlD
Bosutinib—FES—brain—conduct disorder	0.00702	0.0147	CbGeAlD
Bosutinib—TNIK—brain—conduct disorder	0.00689	0.0144	CbGeAlD
Bosutinib—SYK—brain—conduct disorder	0.00689	0.0144	CbGeAlD
Bosutinib—CDK2—brain—conduct disorder	0.00682	0.0143	CbGeAlD
Bosutinib—STK26—brain—conduct disorder	0.00676	0.0141	CbGeAlD
Bosutinib—CHEK2—brain—conduct disorder	0.00653	0.0136	CbGeAlD
Bosutinib—DMPK—brain—conduct disorder	0.00647	0.0135	CbGeAlD
Bosutinib—WEE1—brain—conduct disorder	0.00647	0.0135	CbGeAlD
Bosutinib—STK25—brain—conduct disorder	0.00618	0.0129	CbGeAlD
Bosutinib—EPHA3—brain—conduct disorder	0.00614	0.0128	CbGeAlD
Bosutinib—PLK2—brain—conduct disorder	0.00601	0.0126	CbGeAlD
Bosutinib—SIK3—brain—conduct disorder	0.00597	0.0125	CbGeAlD
Bosutinib—STK4—brain—conduct disorder	0.00575	0.012	CbGeAlD
Bosutinib—CAMK1D—brain—conduct disorder	0.00568	0.0119	CbGeAlD
Bosutinib—STK24—brain—conduct disorder	0.00561	0.0117	CbGeAlD
Bosutinib—FER—brain—conduct disorder	0.00543	0.0114	CbGeAlD
Bosutinib—TYRO3—brain—conduct disorder	0.00543	0.0114	CbGeAlD
Bosutinib—ALK—brain—conduct disorder	0.00543	0.0114	CbGeAlD
Bosutinib—EPHA5—brain—conduct disorder	0.00543	0.0114	CbGeAlD
Bosutinib—LYN—brain—conduct disorder	0.0054	0.0113	CbGeAlD
Bosutinib—MAP4K1—brain—conduct disorder	0.00532	0.0111	CbGeAlD
Bosutinib—MAP3K19—brain—conduct disorder	0.00532	0.0111	CbGeAlD
Bosutinib—BTK—brain—conduct disorder	0.00529	0.0111	CbGeAlD
Bosutinib—TNK2—brain—conduct disorder	0.00522	0.0109	CbGeAlD
Bosutinib—MAP4K2—brain—conduct disorder	0.00515	0.0108	CbGeAlD
Bosutinib—ERBB4—brain—conduct disorder	0.00508	0.0106	CbGeAlD
Bosutinib—STK3—brain—conduct disorder	0.00508	0.0106	CbGeAlD
Bosutinib—ROCK1—brain—conduct disorder	0.00501	0.0105	CbGeAlD
Bosutinib—BMPR2—brain—conduct disorder	0.00487	0.0102	CbGeAlD
Bosutinib—STK36—brain—conduct disorder	0.00483	0.0101	CbGeAlD
Bosutinib—EPHB3—brain—conduct disorder	0.00483	0.0101	CbGeAlD
Bosutinib—MERTK—brain—conduct disorder	0.00477	0.00998	CbGeAlD
Bosutinib—MAP4K4—brain—conduct disorder	0.00468	0.00979	CbGeAlD
Bosutinib—BCR—brain—conduct disorder	0.00465	0.00972	CbGeAlD
Bosutinib—NUAK2—brain—conduct disorder	0.00465	0.00972	CbGeAlD
Bosutinib—MAP3K12—brain—conduct disorder	0.00462	0.00965	CbGeAlD
Bosutinib—MAP2K1—brain—conduct disorder	0.00452	0.00946	CbGeAlD
Bosutinib—STK35—brain—conduct disorder	0.00452	0.00946	CbGeAlD
Bosutinib—CSK—brain—conduct disorder	0.00449	0.0094	CbGeAlD
Bosutinib—CSNK1A1—brain—conduct disorder	0.00447	0.00933	CbGeAlD
Bosutinib—CLK1—brain—conduct disorder	0.00444	0.00927	CbGeAlD
Bosutinib—HCK—brain—conduct disorder	0.00444	0.00927	CbGeAlD
Bosutinib—ABL2—brain—conduct disorder	0.00441	0.00922	CbGeAlD
Bosutinib—CAMK2G—brain—conduct disorder	0.00436	0.0091	CbGeAlD
Bosutinib—BMP2K—brain—conduct disorder	0.00436	0.0091	CbGeAlD
Bosutinib—LRRK2—brain—conduct disorder	0.00432	0.00902	CbGeAlD
Bosutinib—EGFR—brain—conduct disorder	0.0043	0.009	CbGeAlD
Bosutinib—PTK2B—brain—conduct disorder	0.00421	0.00879	CbGeAlD
Bosutinib—CSNK1E—brain—conduct disorder	0.00414	0.00865	CbGeAlD
Bosutinib—SIK1—brain—conduct disorder	0.00407	0.00852	CbGeAlD
Bosutinib—IRAK4—brain—conduct disorder	0.00407	0.00852	CbGeAlD
Bosutinib—EPHA4—brain—conduct disorder	0.00403	0.00843	CbGeAlD
Bosutinib—ERBB3—brain—conduct disorder	0.00399	0.00835	CbGeAlD
Bosutinib—MAP2K2—brain—conduct disorder	0.00398	0.00833	CbGeAlD
Bosutinib—ULK3—brain—conduct disorder	0.00398	0.00833	CbGeAlD
Bosutinib—MAP3K2—brain—conduct disorder	0.00395	0.00827	CbGeAlD
Bosutinib—MAP3K7—brain—conduct disorder	0.00392	0.00819	CbGeAlD
Bosutinib—TBK1—brain—conduct disorder	0.00387	0.0081	CbGeAlD
Bosutinib—PTK2—brain—conduct disorder	0.00387	0.0081	CbGeAlD
Bosutinib—IRAK1—brain—conduct disorder	0.0038	0.00794	CbGeAlD
Bosutinib—RPS6KB1—brain—conduct disorder	0.00373	0.00779	CbGeAlD
Bosutinib—FGR—brain—conduct disorder	0.0037	0.00774	CbGeAlD
Bosutinib—AXL—brain—conduct disorder	0.00369	0.00771	CbGeAlD
Bosutinib—SLK—brain—conduct disorder	0.00355	0.00742	CbGeAlD
Bosutinib—EPHB4—brain—conduct disorder	0.00352	0.00737	CbGeAlD
Bosutinib—EPHA2—brain—conduct disorder	0.00346	0.00723	CbGeAlD
Bosutinib—FYN—brain—conduct disorder	0.00345	0.00722	CbGeAlD
Bosutinib—MAP3K3—brain—conduct disorder	0.00337	0.00705	CbGeAlD
Bosutinib—MAP4K5—brain—conduct disorder	0.00337	0.00705	CbGeAlD
Bosutinib—YES1—brain—conduct disorder	0.00312	0.00651	CbGeAlD
Bosutinib—STK10—brain—conduct disorder	0.00309	0.00645	CbGeAlD
Bosutinib—TAOK3—brain—conduct disorder	0.00308	0.00643	CbGeAlD
Bosutinib—SRC—brain—conduct disorder	0.003	0.00627	CbGeAlD
Bosutinib—MAP2K5—brain—conduct disorder	0.00276	0.00576	CbGeAlD
Bosutinib—CSF1R—brain—conduct disorder	0.00269	0.00562	CbGeAlD
Bosutinib—PDGFRB—brain—conduct disorder	0.00239	0.00499	CbGeAlD
Bosutinib—ABL1—brain—conduct disorder	0.00213	0.00445	CbGeAlD
Bosutinib—ABCB1—brain—conduct disorder	0.000661	0.00138	CbGeAlD
Bosutinib—EGFR—Signaling by GPCR—CGA—conduct disorder	0.000272	0.000522	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—HTR2A—conduct disorder	0.000271	0.00052	CbGpPWpGaD
Bosutinib—PRKCQ—Hemostasis—EP300—conduct disorder	0.000268	0.000514	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—DRD4—conduct disorder	0.000268	0.000513	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—DRD4—conduct disorder	0.000263	0.000504	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—DRD4—conduct disorder	0.000263	0.000504	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—WASF1—conduct disorder	0.000263	0.000504	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—WASF1—conduct disorder	0.000259	0.000496	CbGpPWpGaD
Bosutinib—CSK—Hemostasis—EP300—conduct disorder	0.000259	0.000496	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CGA—conduct disorder	0.000257	0.000493	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—HTR2A—conduct disorder	0.000257	0.000493	CbGpPWpGaD
Bosutinib—EGFR—Direct p53 effectors—EP300—conduct disorder	0.000257	0.000492	CbGpPWpGaD
Bosutinib—SRMS—Immune System—EP300—conduct disorder	0.000254	0.000487	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—DRD4—conduct disorder	0.000254	0.000487	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CGA—conduct disorder	0.000254	0.000486	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—WASF1—conduct disorder	0.000249	0.000478	CbGpPWpGaD
Bosutinib—SYK—Innate Immune System—EP300—conduct disorder	0.000246	0.000471	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—WASF1—conduct disorder	0.000245	0.00047	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—HTR2A—conduct disorder	0.000245	0.00047	CbGpPWpGaD
Bosutinib—EGFR—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.000242	0.000463	CbGpPWpGaD
Bosutinib—EPHA2—Developmental Biology—EP300—conduct disorder	0.000241	0.000463	CbGpPWpGaD
Bosutinib—PRKCQ—Innate Immune System—EP300—conduct disorder	0.000241	0.000463	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CGA—conduct disorder	0.000241	0.000461	CbGpPWpGaD
Bosutinib—CDK2—Cell Cycle, Mitotic—EP300—conduct disorder	0.000241	0.000461	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—WASF1—conduct disorder	0.00024	0.000461	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—WASF1—conduct disorder	0.00024	0.000461	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—WASF1—conduct disorder	0.000239	0.000459	CbGpPWpGaD
Bosutinib—CHEK2—Cell Cycle—EP300—conduct disorder	0.000238	0.000457	CbGpPWpGaD
Bosutinib—EGFR—Immune System—POLR3A—conduct disorder	0.000237	0.000454	CbGpPWpGaD
Bosutinib—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000236	0.000453	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—HTR2A—conduct disorder	0.000235	0.000451	CbGpPWpGaD
Bosutinib—LYN—Immune System—WASF1—conduct disorder	0.000234	0.000449	CbGpPWpGaD
Bosutinib—ABL1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000234	0.000449	CbGpPWpGaD
Bosutinib—ABL1—Immune System—WASF1—conduct disorder	0.000233	0.000447	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—WASF1—conduct disorder	0.000232	0.000444	CbGpPWpGaD
Bosutinib—FYN—Immune System—WASF1—conduct disorder	0.000231	0.000442	CbGpPWpGaD
Bosutinib—MAP2K1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000231	0.000442	CbGpPWpGaD
Bosutinib—SRC—TGF-beta Signaling Pathway—EP300—conduct disorder	0.00023	0.00044	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—WASF1—conduct disorder	0.00023	0.00044	CbGpPWpGaD
Bosutinib—CSNK1E—Cell Cycle, Mitotic—EP300—conduct disorder	0.000229	0.000438	CbGpPWpGaD
Bosutinib—LCK—Immune System—POLR3A—conduct disorder	0.000228	0.000438	CbGpPWpGaD
Bosutinib—CDK2—Hemostasis—EP300—conduct disorder	0.000228	0.000437	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CGA—conduct disorder	0.000226	0.000434	CbGpPWpGaD
Bosutinib—PHKG1—Disease—EP300—conduct disorder	0.000218	0.000418	CbGpPWpGaD
Bosutinib—TXK—Immune System—EP300—conduct disorder	0.000216	0.000414	CbGpPWpGaD
Bosutinib—CDK2—Cell Cycle—EP300—conduct disorder	0.000215	0.000412	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—DRD4—conduct disorder	0.000212	0.000407	CbGpPWpGaD
Bosutinib—ROCK1—GPCR downstream signaling—HTR2A—conduct disorder	0.000212	0.000406	CbGpPWpGaD
Bosutinib—TBK1—Innate Immune System—EP300—conduct disorder	0.000209	0.000401	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—WASF1—conduct disorder	0.000206	0.000395	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—HTR2A—conduct disorder	0.000205	0.000394	CbGpPWpGaD
Bosutinib—CSNK1E—Cell Cycle—EP300—conduct disorder	0.000204	0.000392	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—WASF1—conduct disorder	0.000203	0.00039	CbGpPWpGaD
Bosutinib—SRC—Immune System—POLR3A—conduct disorder	0.000202	0.000387	CbGpPWpGaD
Bosutinib—STK4—Signaling Pathways—EP300—conduct disorder	0.000202	0.000386	CbGpPWpGaD
Bosutinib—EGFR—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.0002	0.000384	CbGpPWpGaD
Bosutinib—EGFR—Immune System—WASF1—conduct disorder	0.000199	0.000382	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CGA—conduct disorder	0.000198	0.000379	CbGpPWpGaD
Bosutinib—BTK—Innate Immune System—EP300—conduct disorder	0.000195	0.000374	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000194	0.000373	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CGA—conduct disorder	0.000193	0.00037	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—WASF1—conduct disorder	0.000193	0.00037	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—HTR2A—conduct disorder	0.000192	0.000369	CbGpPWpGaD
Bosutinib—LCK—Immune System—WASF1—conduct disorder	0.000192	0.000368	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CGA—conduct disorder	0.000189	0.000363	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling by Wnt—EP300—conduct disorder	0.000188	0.00036	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—DRD4—conduct disorder	0.000188	0.00036	CbGpPWpGaD
Bosutinib—IRAK4—Innate Immune System—EP300—conduct disorder	0.000186	0.000357	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CGA—conduct disorder	0.000186	0.000357	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CGA—conduct disorder	0.000185	0.000355	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—DRD4—conduct disorder	0.000184	0.000352	CbGpPWpGaD
Bosutinib—PHKG1—Metabolism—EP300—conduct disorder	0.000183	0.00035	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—WASF1—conduct disorder	0.000182	0.000348	CbGpPWpGaD
Bosutinib—ROCK1—Developmental Biology—EP300—conduct disorder	0.000181	0.000347	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—DRD4—conduct disorder	0.000181	0.000347	CbGpPWpGaD
Bosutinib—FGR—Hemostasis—EP300—conduct disorder	0.000179	0.000344	CbGpPWpGaD
Bosutinib—HCK—Innate Immune System—EP300—conduct disorder	0.000179	0.000343	CbGpPWpGaD
Bosutinib—BCR—Disease—EP300—conduct disorder	0.000178	0.000341	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—DRD4—conduct disorder	0.000176	0.000337	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—HTR2A—conduct disorder	0.000175	0.000335	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—DRD4—conduct disorder	0.000174	0.000334	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—HTR2A—conduct disorder	0.000171	0.000329	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—HTR2A—conduct disorder	0.000171	0.000329	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—EP300—conduct disorder	0.000171	0.000329	CbGpPWpGaD
Bosutinib—SRC—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000171	0.000327	CbGpPWpGaD
Bosutinib—SRC—Immune System—WASF1—conduct disorder	0.00017	0.000326	CbGpPWpGaD
Bosutinib—ERBB4—Innate Immune System—EP300—conduct disorder	0.000168	0.000323	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—DRD4—conduct disorder	0.000168	0.000322	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—DRD4—conduct disorder	0.000168	0.000322	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—HTR2A—conduct disorder	0.000166	0.000318	CbGpPWpGaD
Bosutinib—IKBKE—Immune System—EP300—conduct disorder	0.000164	0.000314	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—DRD4—conduct disorder	0.000162	0.00031	CbGpPWpGaD
Bosutinib—FGR—Innate Immune System—EP300—conduct disorder	0.000162	0.00031	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CGA—conduct disorder	0.000161	0.000308	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—WASF1—conduct disorder	0.000159	0.000304	CbGpPWpGaD
Bosutinib—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000158	0.000303	CbGpPWpGaD
Bosutinib—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000157	0.000301	CbGpPWpGaD
Bosutinib—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000156	0.000299	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CGA—conduct disorder	0.000155	0.000297	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—WASF1—conduct disorder	0.000155	0.000297	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—DRD4—conduct disorder	0.000152	0.000292	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—WASF1—conduct disorder	0.000152	0.000291	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—EP300—conduct disorder	0.00015	0.000287	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—WASF1—conduct disorder	0.000149	0.000286	CbGpPWpGaD
Bosutinib—ERBB3—Innate Immune System—EP300—conduct disorder	0.000149	0.000285	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—WASF1—conduct disorder	0.000148	0.000285	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—EP300—conduct disorder	0.000148	0.000283	CbGpPWpGaD
Bosutinib—PTK2—Hemostasis—EP300—conduct disorder	0.000147	0.000282	CbGpPWpGaD
Bosutinib—YES1—Hemostasis—EP300—conduct disorder	0.000145	0.000278	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—DRD4—conduct disorder	0.000144	0.000276	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—EP300—conduct disorder	0.000144	0.000275	CbGpPWpGaD
Bosutinib—SYK—Immune System—EP300—conduct disorder	0.000143	0.000274	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—DRD4—conduct disorder	0.000142	0.000272	CbGpPWpGaD
Bosutinib—PRKCQ—Immune System—EP300—conduct disorder	0.000141	0.000269	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—HTR2A—conduct disorder	0.000139	0.000266	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CGA—conduct disorder	0.000137	0.000263	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—EP300—conduct disorder	0.000136	0.000261	CbGpPWpGaD
Bosutinib—CSK—Immune System—EP300—conduct disorder	0.000136	0.00026	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—DRD4—conduct disorder	0.000135	0.000258	CbGpPWpGaD
Bosutinib—PTK2—Innate Immune System—EP300—conduct disorder	0.000132	0.000253	CbGpPWpGaD
Bosutinib—YES1—Innate Immune System—EP300—conduct disorder	0.00013	0.00025	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—EP300—conduct disorder	0.00013	0.000249	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—EP300—conduct disorder	0.00013	0.000249	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—EP300—conduct disorder	0.00013	0.000249	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—WASF1—conduct disorder	0.000129	0.000247	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—DRD4—conduct disorder	0.000127	0.000243	CbGpPWpGaD
Bosutinib—CSK—Disease—EP300—conduct disorder	0.000125	0.00024	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—EP300—conduct disorder	0.000125	0.000239	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—WASF1—conduct disorder	0.000124	0.000238	CbGpPWpGaD
Bosutinib—IRAK1—Innate Immune System—EP300—conduct disorder	0.000124	0.000237	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—HTR2A—conduct disorder	0.000122	0.000235	CbGpPWpGaD
Bosutinib—TBK1—Immune System—EP300—conduct disorder	0.000122	0.000233	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—HTR2A—conduct disorder	0.00012	0.00023	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—EP300—conduct disorder	0.000119	0.000229	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—HTR2A—conduct disorder	0.000118	0.000226	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—EP300—conduct disorder	0.000117	0.000224	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—EP300—conduct disorder	0.000116	0.000223	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—EP300—conduct disorder	0.000115	0.000221	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—HTR2A—conduct disorder	0.000115	0.00022	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—HTR2A—conduct disorder	0.000114	0.000218	CbGpPWpGaD
Bosutinib—BTK—Immune System—EP300—conduct disorder	0.000114	0.000218	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—DRD4—conduct disorder	0.000111	0.000212	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—EP300—conduct disorder	0.00011	0.000211	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—WASF1—conduct disorder	0.00011	0.000211	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—EP300—conduct disorder	0.00011	0.00021	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—HTR2A—conduct disorder	0.00011	0.00021	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—HTR2A—conduct disorder	0.00011	0.00021	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—EP300—conduct disorder	0.000109	0.000209	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—EP300—conduct disorder	0.000109	0.000208	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—EP300—conduct disorder	0.000108	0.000208	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—DRD4—conduct disorder	0.000108	0.000207	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—EP300—conduct disorder	0.000108	0.000207	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—EP300—conduct disorder	0.000108	0.000207	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—EP300—conduct disorder	0.000107	0.000206	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—EP300—conduct disorder	0.000106	0.000204	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—DRD4—conduct disorder	0.000106	0.000203	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—HTR2A—conduct disorder	0.000106	0.000202	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—EP300—conduct disorder	0.000105	0.000201	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—DRD4—conduct disorder	0.000104	0.0002	CbGpPWpGaD
Bosutinib—HCK—Immune System—EP300—conduct disorder	0.000104	0.0002	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—DRD4—conduct disorder	0.000104	0.000199	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—EP300—conduct disorder	0.000102	0.000195	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000101	0.000194	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—HTR2A—conduct disorder	9.95e-05	0.000191	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—EP300—conduct disorder	9.93e-05	0.00019	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—EP300—conduct disorder	9.81e-05	0.000188	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—EP300—conduct disorder	9.72e-05	0.000186	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CGA—conduct disorder	9.71e-05	0.000186	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—EP300—conduct disorder	9.68e-05	0.000186	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—EP300—conduct disorder	9.67e-05	0.000185	CbGpPWpGaD
Bosutinib—HCK—Disease—EP300—conduct disorder	9.62e-05	0.000184	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—EP300—conduct disorder	9.57e-05	0.000183	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—EP300—conduct disorder	9.52e-05	0.000182	CbGpPWpGaD
Bosutinib—BLK—Immune System—EP300—conduct disorder	9.44e-05	0.000181	CbGpPWpGaD
Bosutinib—FGR—Immune System—EP300—conduct disorder	9.41e-05	0.00018	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—HTR2A—conduct disorder	9.4e-05	0.00018	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—EP300—conduct disorder	9.36e-05	0.000179	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—HTR2A—conduct disorder	9.27e-05	0.000178	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—EP300—conduct disorder	9.26e-05	0.000177	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—EP300—conduct disorder	9.09e-05	0.000174	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—EP300—conduct disorder	9.09e-05	0.000174	CbGpPWpGaD
Bosutinib—ERBB4—Disease—EP300—conduct disorder	9.06e-05	0.000174	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—DRD4—conduct disorder	9.01e-05	0.000173	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—EP300—conduct disorder	8.85e-05	0.00017	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—HTR2A—conduct disorder	8.79e-05	0.000168	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—EP300—conduct disorder	8.77e-05	0.000168	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—DRD4—conduct disorder	8.68e-05	0.000166	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—EP300—conduct disorder	8.65e-05	0.000166	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—HTR2A—conduct disorder	8.28e-05	0.000159	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—EP300—conduct disorder	8.27e-05	0.000159	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—EP300—conduct disorder	7.99e-05	0.000153	CbGpPWpGaD
Bosutinib—ERBB3—Disease—EP300—conduct disorder	7.99e-05	0.000153	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—EP300—conduct disorder	7.97e-05	0.000153	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—EP300—conduct disorder	7.84e-05	0.00015	CbGpPWpGaD
Bosutinib—PTK2—Immune System—EP300—conduct disorder	7.7e-05	0.000148	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—DRD4—conduct disorder	7.68e-05	0.000147	CbGpPWpGaD
Bosutinib—YES1—Immune System—EP300—conduct disorder	7.59e-05	0.000146	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—EP300—conduct disorder	7.34e-05	0.000141	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HTR2A—conduct disorder	7.23e-05	0.000139	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—EP300—conduct disorder	7.2e-05	0.000138	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HTR2A—conduct disorder	7.06e-05	0.000135	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—EP300—conduct disorder	7.05e-05	0.000135	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HTR2A—conduct disorder	6.91e-05	0.000132	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HTR2A—conduct disorder	6.8e-05	0.00013	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—EP300—conduct disorder	6.78e-05	0.00013	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HTR2A—conduct disorder	6.77e-05	0.00013	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—EP300—conduct disorder	6.34e-05	0.000122	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—EP300—conduct disorder	6.25e-05	0.00012	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—EP300—conduct disorder	6.02e-05	0.000115	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CGA—conduct disorder	5.98e-05	0.000115	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—EP300—conduct disorder	5.93e-05	0.000114	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HTR2A—conduct disorder	5.88e-05	0.000113	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—EP300—conduct disorder	5.8e-05	0.000111	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—EP300—conduct disorder	5.8e-05	0.000111	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—EP300—conduct disorder	5.78e-05	0.000111	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HTR2A—conduct disorder	5.66e-05	0.000109	CbGpPWpGaD
Bosutinib—LYN—Immune System—EP300—conduct disorder	5.66e-05	0.000109	CbGpPWpGaD
Bosutinib—ABL1—Immune System—EP300—conduct disorder	5.64e-05	0.000108	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—EP300—conduct disorder	5.59e-05	0.000107	CbGpPWpGaD
Bosutinib—FYN—Immune System—EP300—conduct disorder	5.57e-05	0.000107	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—EP300—conduct disorder	5.54e-05	0.000106	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—EP300—conduct disorder	5.47e-05	0.000105	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—EP300—conduct disorder	5.34e-05	0.000102	CbGpPWpGaD
Bosutinib—FYN—Disease—EP300—conduct disorder	5.15e-05	9.87e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—EP300—conduct disorder	5.12e-05	9.81e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR2A—conduct disorder	5.01e-05	9.61e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—EP300—conduct disorder	4.98e-05	9.54e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—EP300—conduct disorder	4.91e-05	9.41e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—EP300—conduct disorder	4.82e-05	9.23e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—EP300—conduct disorder	4.66e-05	8.93e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—EP300—conduct disorder	4.64e-05	8.9e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—EP300—conduct disorder	4.45e-05	8.52e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—EP300—conduct disorder	4.38e-05	8.41e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—COMT—conduct disorder	4.38e-05	8.4e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MAOA—conduct disorder	4.35e-05	8.34e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—EP300—conduct disorder	4.28e-05	8.21e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—EP300—conduct disorder	4.11e-05	7.88e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—EP300—conduct disorder	3.83e-05	7.35e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—EP300—conduct disorder	3.79e-05	7.27e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—EP300—conduct disorder	3.74e-05	7.17e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—EP300—conduct disorder	3.66e-05	7.02e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—EP300—conduct disorder	3.6e-05	6.91e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—EP300—conduct disorder	3.58e-05	6.87e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—EP300—conduct disorder	3.11e-05	5.97e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—EP300—conduct disorder	3e-05	5.75e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—COMT—conduct disorder	2.7e-05	5.18e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MAOA—conduct disorder	2.68e-05	5.14e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—EP300—conduct disorder	2.66e-05	5.09e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—EP300—conduct disorder	1.88e-05	3.6e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—EP300—conduct disorder	1.16e-05	2.22e-05	CbGpPWpGaD
